Sorted by Keyword - 1938 word(s), 265 profile(s)

 A

[Anti-cancer drug]

Development of an intranodal administration method

NEXT
PREV
特徴・独自性
  • (1) The amount of anticancer drug required to treat one metastatic lymph node is 1/1,000 to 1/10,000 of the systemic dose.
  • (2) The drug can be administered into the lymph node under ultrasound guidance.
  • (3) An international patent has been filed for the solvent of the administered drug.
実用化イメージ

1. Treatment and prophylactic therapy of affiliated lymph nodes in head and neck cancer, breast cancer, etc.
2. Pharmaceutical companies aiming to develop drugs by drug repositioning and generics
3. Medical device manufacturers aiming to develop a dosing system

Researchers

Graduate School of Biomedical Engineering

Tetsuya KODAMA

[anti-depression]

Prevention and amelioration of late-onset hypogonadism by food ingredients

NEXT
PREV
特徴・独自性
  • Late-onset hypogonadism (LOH) is induced by age-related decline of testosterone synthesis, which leads to decrease muscle and sexual nature as well as mental symptoms such as depression. Now great attention is focused on prevention and amelioration of LOH via ingestion of foods and supplements.
  • We developed screening system of functional ingredients from food extracts for anti-LOH using testis-derived cells, and clarified that vitamins, nutraceuticals, and edible plant extracts have potentiating activities for the production of testosterone.
実用化イメージ

Researchers

Graduate School of Agricultural Science

SHIRAKAWA Hitoshi

[anti-viral]

Development of the next generation anti-HIV agents

NEXT
PREV
特徴・独自性
  • HIV infection is one of most serious concern in infectious diseases. We will perform anti-HIV assays for unmet medical needs in control of HIV infections with established novel assays. We have developed reverse transcriptase inhibitor that has novel mechanism of inhibition, translocation-inhibition (J Biol Chem, 2009). Dr Kodama participated in the primary screening and development of a new HIV integrase inhibitor, elvitegravir (J Virol 2009), and a unique reverse transcriptase inhibitor, islatravir, which phase III clinical trials by the Merck & Co., Inc. will complete, soon. We have a representative resistant HIV strain-library for anti-HIV screening and several target oriented high through-put screening systems.
実用化イメージ

We can establish high through-put screening for new targets, so please consult with us individually. We are open to joint development requiring BSL3/P3 experimental facilities and academic guidance including other microorganisms.

Researchers

International Research Institute of Disaster Science

Eiichi Kodama

[antibiotics]

Novel high-throughput screening systems for new antibiotics targeting bacterial virulence factors

NEXT
PREV
特徴・独自性
  • Chemotherapy toward bacterial infection, which dates back to the discovery of penicillin, opened up the golden era of antibiotics. Thereafter, various clinically important antibiotics were introduced into the clinic, and hence serious bacterial infectious diseases were eradicated. However, this ephemeral hope has been disappearing due to the emergence of antibiotic resistant pathogens toward every new antibiotics launched into the clinic, such as multidrug-resistant Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA). To combat these life-threatening pathogens, there is a pressing need to develop new antibiotics. However, new antibiotics discovered in the future will be nullified by development of resistance to these antibiotics, since their targets are essential for bacterial survival. From this aspect in which inhibitors of the essential functions inevitably select resistant mutants, bacterial virulence could be a fascinating target for developing new antibiotics, because virulence attenuators are thought to be less likely to generate resistance. We focus on a novel protein translocation system, Tat, since this system appears to be involved in several aspects of bacterial virulence and is not present in mammalian cells, and iron-metabolism-associated system as novel targets for development of their inhibitors. We hope to conduct collaborative research with a willing company for a practical application of this technology in industry.
実用化イメージ

Researchers

Graduate School of Agricultural Science

Hiroshi Yoneyama

[antibody]

Peptide and Protein Designs for Unexplored Fileds

NEXT
PREV
特徴・独自性
  • I am proposing methodologies to design recombinant peptides and proteins with appropriate structures and functions in the medicinal, environmental, material, and nanotechnological fields, with molecular evolutional and domain shuffling engineering. At present, we have constructed the methodologies for efficient renaturation of functional proteins from inclusion bodies expressed in bacteria, generation of peptides and proteins with the function of biomineralization, generation of peptides and proteins with affinity for inorganic materials to spontaneously make linkages between various nanomaterials, and high enhancement of cellulolytic enzyme activity induced by nanoclustering design on nanomaterials.
実用化イメージ

We hope the business partners in the in the medicinal, environmental, material, and nanotechnological fields would be interested in my approaches and we could conduct effective collaboration research with them.

Researchers

Graduate School of Engineering

Mitsuo Umetsu

Bio-Hybrid MEMS for Medical, Environmental and Food Engineering

NEXT
PREV
特徴・独自性
  • We have developed original manufacturing techniques for bio-hybrid MEMSs that utilize special functions of bio-elements, proteins and living cells, for molecular selective sensing and power generation from natural fuels.
  • (1) Conducting polymer electrodes printed on hydrogels (image 1)
  • (2) Dynamic control of bio-adhesion by electrochemical means (image 2)
  • (3) Micro Biofuel Cells with flexible enzyme electrode patches (image 3)
実用化イメージ

We hope to conduct collaborative research with a willing company for a practical application of these technologies in industry.

Researchers

Graduate School of Engineering

Matsuhiko Nishizawa

[antibody drug]

Production of Tumor-Specific Monoclonal Antibodies

NEXT
PREV
特徴・独自性
  • Podoplanin (PDPN/Aggrus/T1α), a platelet aggregation-inducing mucin-like sialoglycoprotein, is highly expressed in many cancers and normal tissues. A neutralizing monoclonal antibody (mAb; NZ-1) can block the association between podoplanin and C-type lectin-like receptor-2 (CLEC-2) and inhibit podoplanin-induced cancer metastasis, but NZ-1 reacts with podoplanin-expressing normal cells such as lymphatic endothelial cells. Recently, we established a platform to produce cancer-specific mAbs (CasMabs). The newly established LpMab-2 mAb reacted with podoplanin-expressing cancer cells but not with normal cells, as shown by flow cytometry and immunohistochemistry; therefore, LpMab-2 is an anti-podoplanin CasMab that is expected to be useful for molecular targeting therapy against podoplanin-expressing cancers.
実用化イメージ

We can produce cancer-specific mAbs (CasMabs) against all membranous proteins. CasMabs are expected to be useful for molecular targeting therapy without side effects.

Researchers

Graduate School of Medicine

Yukinari Kato

[Antisense]

Development of Intelligent Molecules for the Regulation of Gene Expression in Cells

NEXT
PREV
特徴・独自性
  • The artificial control of gene expression by synthetic oligodeoxynucleotides (ODNs) has been the subject of considerable interest. In particular, ODNs conjugated with a cross-linking agent have been expected to enhance the inhibitory effect. Recently, microRNAs (miRNA) endogenously expressed small regulatory non-coding RNAs, are recognized as playing a critical role in regulating gene expression and the great concerns have been raised about efficient antisense oligonucleotides against miRNAs. We have already demonstrated that ODNs bearing a 2-amino-6-vinylpurine (2-AVP) derivative exhibited efficient interstrand cross-linking to cytosine selectively. The unique structural features of AVP are to possess both the hydrogen bond donor-acceptor sites as recognition sites and the vinyl group as a reactive moiety in a single molecule. Recently, we have developed of the novel cross-linking agents, which are designed based on the unique structure of AVP. These derivatives can react to thymine at the complementary site with highly selective and efficient under neutral conditions. We hope to conduct collaborative research with a willing company for a practical application of this technology in industry.
実用化イメージ

Researchers

Institute of Multidisciplinary Research for Advanced Materials

Fumi Nagatsugi

[Aortic aneurysm and disection]

Development of preventive medicine for aortic aneurysm and dissection of Marfan syndrome

NEXT
PREV
特徴・独自性
  • Marfan’s syndrome (MF) is a severe, systemic disorder of connective tissue formation. A variety of MFS therapies have been developed, including surgical therapy for aortic root aneurysm and dissection (AAD) that are life-threatening, traditional medical therapies such as β-adrenergic receptor or angiotensin II receptor blockers for slow aortic growth and to decrease the risk of AAD. However these treatments did not prevent tissue destruction in the AAD of MF. To develop preventive strategy for AAD, it will be necessary to identify molecular mechanisms of microfibril formation and an appropriate fibrillin-1 microfibril associated molecule. Recently, ADAMTSL6β, which is a microfibril-associated extracellular matrix protein contributes the regeneration of microfibril by promoting fibrillin-microfibril assembly. We try to develop ADAMTSL6β as a preventive medicine for AAD of MF by regeneration of fibrillin-1 microfibril assembly.
実用化イメージ

Researchers

Graduate School of Dentistry

Masahiro Saito

[apoplexy]

Development of a novel therapeutic drug, TMS-007, for acute cerebral infarction

特徴・独自性
  • The currently approved fibrynolytic therapy is only alteplase, but the use of it has been limited to 5% of patients with acute cerebral infarction due to possible side effects including hemorrhagic infarction that may be life-threatening. TMS-007 is a novel drug that has both fibrynolytic activity and brain protective effects. The aim of this project is to perform a clinical trial of this drug and to further achieve a commercial-based clinical use. We believe that this drug would contribute significantly in the treatment of acute cerebral infarction.
実用化イメージ

Researchers

Administrative Staff

Teiji Tominaga

[Appetite]

Development of New Drugs and Devices Regulating Inter-Organ Neural Network for Obesity Therapy

NEXT
PREV
特徴・独自性
  • Obesity induced the metabolic syndrome, which causes cardiovascular diseases. Obesity has now become a major health concern not only in developed countries but developing countries. However, diet and exercise are still major therapies. We discovered endogenous systems maintaining homeostasis of energy metabolism and revealed several neuronal networks among organs to be responsible for the regulation systems.
  • 1) Afferent neuronal signals from adipose tissue regulate appetite and prevent over-eating during obesity development (Cell Metab 2006)
  • 2) Neuronal network from the liver enhances basal metabolic rates to prevent obesity development when energy store is increasing (Science 2006) 3) Neuronal network from the liver suppresses adaptive thermogenesis in brown adipose tissue (Cell Metab 2012).
実用化イメージ

On the basis of these original discoveries, we are aiming at developing new drugs and/or building devices which regulate the inter-organ neuronal networks and hope to conduct collaborative research with a willing company for a practical application to obesity therapy.

Researchers

Graduate School of Medicine

Hideki Katagiri

[Applied Ethics(Engineering Ethics etc.)]

Philosophy of Science and Technology, Science and Technology Studies (STS)

NEXT
PREV
特徴・独自性
  • My research area is mainly phenomenology, philosophy of technology, and applied ethics (engineering ethics etc.). Technological Artifacts mediate human activities. So designing artifacts is in itself an ethical behavior. Analysing the ontological structure of the artifacts, describing the epistemological propcess of desingning activities, evaluating the social and ethical influence of artifacts are main issues in philosophy of technology. On the basis of such philosophical investigations, we can develope ethical studies concerining how engineerss, companies can recognize ethical issues in a networks of meanings , how they can make ethical decision among engineers and users.
実用化イメージ

I hope to conduct cooperative research on ethical education of engineers, as well as on human-machine interaction.

Researchers

Graduate School of Arts and Letters

Kiyotaka Naoe

[applied mathematics]

Mathematical Biology

NEXT
PREV
特徴・独自性
  • Principal subject of our study is the mathematical model analysis to make clear or present the point at issue for scientific discussion about real biological/social phenomena, or to promote the advanced theoretical research: what theoretical problem about target phenomenon is treated, how the problem is mathematically modeled, what mathematical analysis is applied for the model, and how the mathematical result is lead to the discussion in biological/social science.
実用化イメージ

Researchers

Graduate School of Information Sciences

Hiromi Seno

[Aquatic Organisms]

Construction of Monitoring Systems for Genetic Diversity in Aquatic Organisms

NEXT
PREV
特徴・独自性
  • Maintaining genetic diversity within a species is a major issue to conserve biodiversity and sustainable use. To monitor genetic diversity in natural and captive populations using adequate genetic markers is the most important step. We have focused aquatic organisms and studied the genetic diversity using an array of DNA analyses. Our research interest includes 1) genetic structure and phylogeography of natural populations in marine and freshwater organisms and 2) genetic management of commercially important species to contribute the stock enhancement programs.
実用化イメージ

Our skill can be applied to environmental assessment and fish resource management. We are collaborating with national institutes and giving advice to private environmental assessment companies.

Researchers

Graduate School of Agricultural Science

Minoru Ikeda

[Architecture Integration]

Novel-Concept Silicon Integrated Circuits Derived from the 3-Dimensional Device, Circuit and Architecture

NEXT
PREV
特徴・独自性
  • In recent year, facing the age of nanoscale engineering, the new technologies of device, circuit and architecture supported by novel physical guidance principles are highly expected, just as the similar situation as the predawn of semiconductor technology when Bardeen and Shockley discovered the secret of transistors. Therefore, in our research approach, the architectures, circuits, devices and CAD design tools for nanoscale LSI are systematically investigated in the following three main research subjects.
  • 1. Study on nanoscale device and circuit
  • Aiming at the nanoscale silicon semiconductor integrated circuit, we are mainly working on the following directions for new devices and circuits:
  • ①Analysis for novel physical phenomenon based on nanostructural effects
  • ②Device and circuit technology with new operating principle
  • ③Restraint technology for increasing variability of device characteristics
  • ④Architecture and circuit technology for robust information processing
  • 2. Study on the 3-dimention-structual device and circuit
  • The elementary element of recent LSI with planar-structural devices is coming close to the physical limitation of scaling. In order to break the limit and sustain the evolution of future LSI performance, we have started the research on the novel 3-dimension-structural devices and circuits.
  • 3. research on wireless integrated circuit (IC) based on information transmission
  • The ultracompact lightweight wireless IC is one of essential technologies for realizing the ubiquitous society which has the network available in anywhere, at anytime and from any surrounding items. For example, the IC tags for receiving information with reading function are getting close to the practical applications. In our laboratory, aiming at the automatic operating wireless IC with embedded power supply, we are systematically working on the following directions:
  • ①The electrical power generation and storage devices
  • ②Devices and circuits with Ultralow power consumption
  • ③Sensing devices
  • For all above subjects, We hope to conduct collaborative researches with companies interested in our research.
実用化イメージ

Researchers

Graduate School of Engineering

Tetsuo Endoh

[Aromatase]

Hormone Actions in Human Breast Carcinoma

NEXT
PREV
特徴・独自性
  • Breast cancer is one of the most common malignancies in women worldwide. Therefore, it is very important to investigate biological features of breast carcinoma in order to improve clinical outcome of the patients. It is well known that estrogens play important roles in the development of human breast carcinomas, and endocrine therapies are frequently used in these patients to block the intratumoral estrogen actions. In the Division of Pathology and Histotechnology, we analyze hormone actions in breast carcinoma by pathological methods as well as various molecular biological techniques.
実用化イメージ

It will be possible to newly develop diagnostic techniques regarding prediction of prognosis and/or effectiveness of treatment in breast cancer patients.

Researchers

Graduate School of Medicine

Takashi Suzuki

[Arthritis]

Development of Recombinant Inbred Mice with a Genetic Predisposition to Collagen Disease

NEXT
PREV
特徴・独自性
  • Eleven strains of recombinant inbred (RI) mice derived from MRL/lpr and C3H/lpr mice were established. This RI is the only one in the world that randomly develops lesions such as nephritis, arthritis, sialadenitis, vasculitis, and production of autoantibodies in each strain. The genomes of the two strains of mice are randomly held in homozygous condition, and the phenotypes of each strain and the effects of administered drugs could be compared based on their genotype maps. It is possible to identify the regions of gene loci involved in the phenotype and drug sensitivity.
実用化イメージ

Development of diagnostic and therapeutic agents for autoimmune diseases. It can be applied to the elucidation of the mechanism of onset of immunological adverse events caused by immune checkpoint inhibitors and the development of drugs to prevent the onset of such events, and industry-academia collaboration with pharmaceutical companies, test reagent companies, etc. is possible.

Researchers

Graduate School of Biomedical Engineering

Tetsuya KODAMA

Development of McH-lpr/lpr-RA1 mouse, a study model that spontaneously develops severe autoimmune arthritis, vasculitis, and sialadenitis

NEXT
PREV
特徴・独自性
  • McH/lpr-RA1 mice are recombinant congenic mice descended from MRL/lpr and C3H/lpr mice and develop arthritis, vasculitis, and sialadenitis with high frequency and severity, with severe pannus formation similar to rheumatoid arthritis, polyarteritis nodosa, and Sjogren's syndrome. On the other hand, McH/lpr-RA1 mice do not develop systemic lymphadenopathy and severe nephritis as seen in MRL/lpr mice, so they are easy to breed and maintain and can be used for long-term drug administration experiments.
実用化イメージ

Development of diagnostic and therapeutic agents for collagen diseases. It can be applied to the elucidation of the mechanism of onset of immunological adverse events caused by immune checkpoint inhibitors and the development of drugs to prevent the onset of such events, etc. Industry-academia collaboration with pharmaceutical companies, test reagent companies, etc. is possible.

Researchers

Graduate School of Biomedical Engineering

Tetsuya KODAMA

[Artificial Nucleoside]

Development of Intelligent Molecules for the Regulation of Gene Expression in Cells

NEXT
PREV
特徴・独自性
  • The artificial control of gene expression by synthetic oligodeoxynucleotides (ODNs) has been the subject of considerable interest. In particular, ODNs conjugated with a cross-linking agent have been expected to enhance the inhibitory effect. Recently, microRNAs (miRNA) endogenously expressed small regulatory non-coding RNAs, are recognized as playing a critical role in regulating gene expression and the great concerns have been raised about efficient antisense oligonucleotides against miRNAs. We have already demonstrated that ODNs bearing a 2-amino-6-vinylpurine (2-AVP) derivative exhibited efficient interstrand cross-linking to cytosine selectively. The unique structural features of AVP are to possess both the hydrogen bond donor-acceptor sites as recognition sites and the vinyl group as a reactive moiety in a single molecule. Recently, we have developed of the novel cross-linking agents, which are designed based on the unique structure of AVP. These derivatives can react to thymine at the complementary site with highly selective and efficient under neutral conditions. We hope to conduct collaborative research with a willing company for a practical application of this technology in industry.
実用化イメージ

Researchers

Institute of Multidisciplinary Research for Advanced Materials

Fumi Nagatsugi

[artificial nuculeic acids]

Creation of cancer cell specific oligonucleotide therapeutics

NEXT
PREV
特徴・独自性
  • Focusing our reseach interest mostly on the recognition and complexation behavior control of bioplymrs, such as DNA/RNA, proteines and so on. Another topics are reaction control based on molecular recognition phenomena in both ground and electronically excited states, we are pursuing mechanistic and synthetic studies on asymmetric photochemistry with supramolecular biopolymers as chiral reaction fields.
実用化イメージ

Researchers

Institute of Multidisciplinary Research for Advanced Materials

Takehiko Wada